-Frontline Reinstatement of the fundamental right to property in the Constitution will on its own do little to protect the interests of poor peasants and traditional communities.  The Indian Constitution adopted in 1950 guaranteed a set of fundamental rights that cannot be abridged by Central or State laws. One of these fundamental rights was the right to property enshrined in Articles 19(1)(f) and 31. Article 19(1)(f) guaranteed to all citizens the right...

-The Hindu Icann, the global authority dealing with domain names, is hastening the threat of monopolisation on the internet through its new scheme to sell generic words L’Oréal has applied for the top level domain (TLD) .beauty to the Internet Corporation for Assigned Names and Numbers (Icann), the global authority dealing with domain names on the Internet. TLDs are what we see on the right side of the dot in domain names...

-The Hindu Building ‘capitalism with Indian characteristics’ means decisions cannot ignore concerns of voters and communities As the economy slows down and the rupee wilts, Manmohan Singh has bitten the ‘reforms’ bullet with both eyes on the credit rating agencies whose negative reports have done much to dampen the ‘animal spirits’ of investors, foreign and native. Last November, when the Congress party made a push to introduce foreign direct investment in multi-brand retail,...

-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...

-Live Mint Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi high court on Friday over the Indian company’s generic copy of lung cancer drug Tarceva after a four-year court battle. Justice Manmohan Singh observed in his 280-page judgement that it had been scientifically proven that Cipla’s generic version was a polymorph B variant of Roche’s patented drug and that it didn’t actually...